Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Allergy Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Allergy Other
    Ultra-Short Course of Subcutaneous Immunotherapy Well Tolerated in Patients With Seasonal Allergic Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Sublingual Immunotherapy Even More Effective During Pollen Peak Season in Children With Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Children and Adolescents With Grass-Pollen-Allergic Rhinoconjunctivitis Benefit Similarly From 5-Grass Sublingual Monotherapy: Presented at EAACI - (DGDispatch)
    Sublingual Monotherapy Improves Quality of Life in Polysensitised Patients With Allergic Rhinitis: Presented at EAACI - (DGDispatch)
    Recombinant Bet v 1 Sublingual Tablets in Birch Allergy Well Tolerated Up to 50 mcg: Presented at EAACI - (DGDispatch)

    News archive

     Recent webcasts/CME - Allergy Other
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
    • Improving Outcomes for Patients With Allergic Rhinitis: An Update From Philadelphia
    • Recognition and Management of Anaphylaxis

      Webcasts/CME archive

       Recent cases - Allergy Other
        Acute Allergic Reaction due to Milk Proteins Contaminating Lactose Added to Corticosteroid for Injection
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        Anaphylactic Reaction to Camomile Tea
        Acute Allergic Interstitial Nephritis After Use of Pantoprazole
        Allergic Enterocolitis and Protein-Losing Enteropathy as the Presentations of Manganese Leak From an Ingested Disk Battery: A Case Report

        Cases archive
          




        my personal edition > allergy other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Oral Immunotherapy for Peanut Anaphylaxis With Peanut Flour and Peanuts: Presented at ACAAI

        By Carole Bullock

        DALLAS, TX -- November 16, 2007 -- An oral peanut flour challenge provided a novel immunotherapy for peanut allergies, according to a small study, reported here at the American College of Allergy, Asthma and Immunology (ACAAI) 65th annual meeting.

        "Peanut anaphylaxis (PA) and other food anaphylaxis is a cause of great anxiety in parents and young children. Avoidance and autoinjectors of epinephrine are not always successful," Lyndon Mansfield, MD, Director, Western Sky Medical Research, El Paso, Texas, United States, said in a presentation on November 12.

        "Even though sublingual immunotherapy with peanut extract has been reported to offer protection against PA, the reagent is not available for clinical use," he noted.

        The researchers explored the novel immunotherapy in group of 7 patients with PA, using a carefully monitored oral peanut flour challenge. The dose was gradually increased to 8 grams of peanut flour twice daily. Maintenance dosing was either peanut flour or 4 to 8 peanuts first BID, then QD and QOD.

        "Our longest clinical experience is 30 months without any further PA in spite of several small accidental exposures to peanut or peanut butter," he reported.

        The researchers said that their protocol can "provide clinical benefit for patients, particularly young children, who cannot self-administer epinephrine and control accidental exposures."

        Commenting on the research, Joseph Bellanti, MD, Professor of Pediatrics and Microbiology/Immunology, Georgetown University, Washington, DC, United States, said, "The study shows the technique is successful and an a sublingual alternative, but is needs to have standardisation to make sure patients aren't put at risk for anaphylaxis."

        No funding was provided for this study. The author and commentator have no disclosures.


        [Presentation title: Oral Immunotherapy For Peanut Anaphylaxis (Pa)With Peanut Flour and Peanuts (PFAP). Abstract 50]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send